文献速递妇科

异常腹膜细胞学对I-II期子宫内膜样子宫内膜癌患者生存的影响

Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2018-03-28

多中心回顾性研究纳入1668例I-II期子宫内膜样子宫内膜癌患者,异常腹膜细胞学与无病生存期(HR 3.07,P<0.001)和病因特异性生存期(HR 3.42,P=0.008)降低独立相关,且与远处复发风险增加相关(5年率8.8% vs 3.6%,P=0.001),术后化疗可降低异常腹膜细胞学患者的腹膜复发率(5年率1.3% vs 9.2%,P=0.039)。

要点

  • 异常腹膜细胞学与I-II期子宫内膜样子宫内膜癌患者无病生存期和病因特异性生存期降低独立相关。
  • 异常腹膜细胞学与远处复发风险增加相关(5年率8.8% vs 3.6%),但与局部复发无显著相关(5年率5.2% vs 3.0%,P=0.32)。
  • 在I期低风险组中,异常腹膜细胞学与远处复发风险增加相关(5年率5.5% vs 1.0%,P<0.001)。

核心结论

  • 本研究提示异常腹膜细胞学可能是I-II期子宫内膜样子宫内膜癌患者生存期降低的预后因素,尤其对低风险组。

研究设计与样本

  • 多中心回顾性研究,纳入2000年至2015年间接受初次子宫切除术且腹膜细胞学结果可用的1668例I-II期子宫内膜样子宫内膜癌患者。

主要发现

  • 恶性细胞和异型细胞分别见于125例(7.5%)和58例(3.5%)患者。
  • 多因素分析显示,非肥胖、非糖尿病、吸烟和淋巴血管间隙浸润与异常腹膜细胞学独立相关(均P<0.05)。
  • 多因素分析显示,异常腹膜细胞学与无病生存期降低(风险比3.07,P<0.001)和病因特异性生存期降低(风险比3.42,P=0.008)独立相关。
  • 与细胞学阴性相比,异常腹膜细胞学与远处复发风险增加显著相关(5年率:8.8% vs 3.6%,P=0.001),但与局部复发无显著相关(5年率:5.2% vs 3.0%,P=0.32)。
  • 在I期低风险组中,异常腹膜细胞学与远处复发风险增加显著相关(5年率:5.5% vs 1.0%,P<0.001),但在高-中风险组中无显著相关(13.3% vs 10.8%,P=0.60)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine survival of women with stage I-II endometrioid endometrial cancer whose peritoneal cytology showed malignant or atypical cells (abnormal peritoneal cytology). METHODS: This is a multi-center retrospective study examining 1668 women with stage I-II endometrioid endometrial cancer who underwent primary hysterectomy with available peritoneal cytology results between 2000 and 2015. Abnormal peritoneal cytology was correlated to clinico-pathological characteristics and oncological outcome. RESULTS: Malignant and atypical cells were seen in 125 (7.5%) and 58 (3.5%) cases, respectively. On multivariate analysis, non-obesity, non-diabetes mellitus, cigarette use, and lympho-vascular space invasion were independently associated with abnormal peritoneal cytology (all, P<0.05). Abnormal peritoneal cytology was independently associated with decreased disease-free survival (hazard ratio 3.07, P<0.001) and cause-specific survival (hazard ratio 3.42, P=0.008) on multivariate analysis. Abnormal peritoneal cytology was significantly associated with increased risks of distant-recurrence (5-year rates: 8.8% versus 3.6%, P=0.001) but not local-recurrence (5.2% versus 3.0%, P=0.32) compared to negative cytology. Among women with stage I disease, abnormal peritoneal cytology was significantly associated with an increased risk of distant-recurrence in the low risk group (5-year rates: 5.5% versus 1.0%, P<0.001) but not in the high-intermediate risk group (13.3% versus 10.8% P=0.60). Among 183 women who had abnormal peritoneal cytology, postoperative chemotherapy significantly reduced the rate of peritoneal recurrence (5-year rates: 1.3% versus 9.2%, P=0.039) whereas postoperative radiotherapy did not (7.1% versus 5.5%, P=0.63). CONCLUSION: Our study suggests that abnormal peritoneal cytology may be a prognostic factor for decreased survival in women with stage I-II endometrioid endometrial cancer, particularly for low-risk group.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Matsuo K, Yabuno A, Hom MS, et al. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer. Gynecol Oncol. 2018. PMID: 29605499. doi:10.1016/j.ygyno.2018.02.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。